US$ 22.18
does ghk-cu build tolerance or lose effectiveness over time How Often to Inject GHK-Cu Peptides Before and After:
Description
34 , 15141531.e7 (2022)

Neurodegenerative diseases such as Alzheimers disease (AD), Parkinsons disease, amyotrophic lateral sclerosis (ALS), and Huntingtons disease represent an escalating global health challenge, driven by an aging population and the lack of effective disease-modifying therapies

Even a previous foot surgery can act as a triggering event

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
There is no competition between them
Just to get a sense how complex this process is, here is roughly how CPI is calculated
